|
|
|
Dynamics of Retinal Photocoagulation Since
its introduction nearly 40 years ago, laser photocoagulation remains the
standard of care for long-term therapy of several retinopathies. Pan-retinal photocoagulation
(PRP), for example, is highly effective to reverse angiogenesis, and focal
laser therapy is effective for treating macular edema. Unfortunately,
multiple adverse effects often follow these treatments, including decreased
peripheral, color, and night vision and retinal scars that can enlarge
postoperatively and cause choroidal neo-vascularization, sub-retinal fibrosis and additional
visual field loss. Despite
widespread use of lasers in retinal therapy, a systematic clinico-pathological
analysis of laser-induced retinal lesions and their evolution over time is
largely lacking. Moreover, it remains largely unknown how the benefits of PRP
or its many deleterious side effects relate to parameters of laser treatment
and subsequent retinal healing. Thus strategies to reduce untoward effects of
PRP while maintaining clinical benefit are highly desirable. We
developed a new method of retinal photocoagulation using Pattern Scanning
Laser (PASCAL). In this approach patterns of
multiple pulses are applied during the eye fixation time (under half a
second) using a scanning laser with pulse durations in the range of 10-30
ms. In addition to much faster and
less painful delivery of the PRP treatment, PASCAL enabled the sub-visible
treatments and sparked renewed interest in research of retinal
photocoagulation. This technology has been licensed to OptiMedica Corp.
We study dynamics of retinal photocoagulation and
adverse events, such as vaporization and rupture in millisecond and
microsecond ranges of pulse duration. We
developed a computational model of retinal photocoagulation and rupture that
helps optimizing the laser treatment parameters for enhancement of the safe
therapeutic range of the short-pulse retinal photocoagulation. We develop a minimally-traumatic approach to
retinal laser therapy utilizing the effect of retinal plasticity. We also
work on minimally-traumatic approach to laser therapy of glaucoma, and on
computer-guided ocular laser therapies. |